Insider Transactions in Q2 2022 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2022
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,930
-17.16%
|
-
|
|
Jun 28
2022
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+36.94%
|
-
|
|
Jun 22
2022
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
6,152
-21.81%
|
$36,912
$6.61 P/Share
|
|
Jun 22
2022
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,152
+17.91%
|
$24,608
$4.13 P/Share
|
|
Jun 21
2022
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
143,848
-86.71%
|
$863,088
$6.59 P/Share
|
|
Jun 21
2022
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
143,848
+46.44%
|
$575,392
$4.13 P/Share
|
|
May 20
2022
|
David S Tierney Director |
SELL
Open market or private sale
|
Direct |
20,000
-6.09%
|
-
|
|
May 20
2022
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+5.74%
|
$40,000
$2.53 P/Share
|